99

Assessment of Impacts Policy options- Full list of actions Economic 3B Identify good practices and benchmarks for the Blue Biotechnology sector, by building on existing biotechnology practices (SO1) 3C Facilitate programmes, matchmaking events and roadshows for Blue Biotech SMEs as part of broader initiatives for biotechnology and emerging sectors (in order to increase visibility) (SO1 + SO3) 3D Provide extensive guidance to stakeholders on how existing provisions related to biotechnology can be implemented and utilised within the context of Blue Biotechnology (SO2) 3E Promote the use of support mechanisms for start-ups and SMEs that collaborate with research centres and private investors at an early stage of the product development process (SO2) 3F Foster the development of a live database of biotechnology SMEs and products, and include Blue Biotechnology as a category (SO2) 3G Promote Blue Biotech financing through existing financing instruments 3H Assess and promote the blue component of financial mechanisms such as the EU Structural Funds or Horizon 2020 and set targets for several sectors (earmarking) (SO3) Total scores policy option 3 Average score per individual policy action 4 4A Formal policy measures Increase the visibility of the Blue Biotechnology sector by proposing a specific NACE code for (Blue) Biotechnology (allowing for increased visibility by defining the sector) (SO1) 4B Create a register for Blue Biotech firms (SO1); 4C Establish a (stand-alone) Blue Biotechnology fund through a joint initiative of EC DG MARE and the EIB (similar to JESSICA, JEREMIE, JASPERS) (SO3); 4D Promote legal measures to establish a licensing and environmental impact assessment framework within UNCLOS as well as a common benefit mechanism and sharing fund (SO4). Total scores policy option 4 Average score per individual policy action ++ + Social Environmental + + + + + ++ + 9 1.1 1 0.1 0 ++ - +++ + +++ +++ 10 2.5 1 0.2 3 0.8 74 Study in support of Impact Assessment work on Blue Biotechnology

100 Publizr Home